Carregant...

Once-Weekly Injection of Low-Dose Teriparatide (28.2 μg) Reduced the Risk of Vertebral Fracture in Patients with Primary Osteoporosis

We conducted a randomized, double-blind trial to assess the effect of 28.2 μg teriparatide versus placebo (1.4 μg teriparatide) on reduction of the incidence of vertebral fractures. Individuals enrolled in this study included patients with primary osteoporosis with one to five vertebral fractures an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fujita, Takuo, Fukunaga, Masao, Itabashi, Akira, Tsutani, Kiichiro, Nakamura, Toshitaka
Format: Artigo
Idioma:Inglês
Publicat: Springer US 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3899450/
https://ncbi.nlm.nih.gov/pubmed/23963633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-013-9777-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!